- Moderna has begun human trials for a potential new influenza vaccine.
- The new vaccine uses mRNA technology, the same technology used to create the Moderna and Pfizer COVID-19 vaccines.
- If successful, the vaccine could be more effective than the current flu shot.
On July 7, 2021, Moderna announced that participants received vaccination doses in the Phase 1/2 study of mRNA-1010, the company’s seasonal influenza mRNA vaccine for healthy adults in the United States.
This is Moderna’s first seasonal influenza vaccine candidate to enter the clinic and targets lineages recommended by the World Health Organization (WHO) for the prevention of influenza.
The vaccination aims to fight against influenza A H1N1, H3N2, and influenza B Yamagata and Victoria.
Moderna plans to enroll about 180 participants in the study.
Source: healthline